Christopher R. Loose, Chief Scientific Officer at Frequency Therapeutics, Inc. (FREQ), sold 24,000 shares at $19.46 ($485K) on 2020-10-06, disclosed to the SEC on 2020-10-08.
Open-market sale of $485k FREQ by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.46 | 8,000 | $156K | 32.1% |
| 2 | $20.00 | 8,000 | $160K | 33.0% |
| 3 | $21.12 | 8,000 | $169K | 34.9% |
| Total | $20.19 avg | 24,000 | $485K | 100% |
| Filing → |
| FREQ | SELL | 2023-07-25 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-21 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-19 | $2K | — | Filing → |